- Phone
-
Address
Room 4494, Building 6, No. 111 Fengpu Avenue, Fengpu Industrial Zone, Fengxian District, Shanghai
Product Categories
Shanghai Qiansi Biotechnology Co., Ltd
Human Mumps Virus IgG Kit
NegotiableUpdate on 05/06
- Model
- Nature of the Manufacturer
- Producers
- Product Category
- Place of Origin
Overview
The human mumps virus IgG kit mostly uses ELISA technology to detect IgG antibodies in samples. High sensitivity, strong specificity, and easy operation, used for diagnosis, prevention and control, and vaccine evaluation, requiring compliance with regulations.
Product Details
Human Mumps Virus IgG Kit
Human Mumps Virus IgG KitIt is an important tool for detecting mumps virus IgG antibodies in human serum, plasma, or other related liquid samples, and is of great significance in mumps diagnosis, disease prevention and control, and vaccine efficacy evaluation.
These types of test kits often use enzyme-linked immunosorbent assay (ELISA) technology. The principle is based on antigen antibody specific binding. The mumps virus antigen is pre packaged on a microplate in the reagent kit. After adding the sample to be tested, if mumps virus IgG antibody is present in the sample, it will bind to the solid-phase antigen to form an antigen antibody complex. Subsequently, the enzyme-linked secondary antibody is added, which binds to the already bound IgG antibody to construct an antigen antibody enzyme-linked secondary antibody complex. After adding the substrate, under the catalysis of the enzyme, the substrate undergoes a color reaction, and the depth of the color is proportional to the IgG antibody content in the sample. By measuring the absorbance (OD value) at a specific wavelength using an enzyme-linked immunosorbent assay (ELISA) reader, and then using the standard curve provided by the kit, the concentration of mumps virus IgG antibody in the sample can be accurately calculated.
The human mumps virus IgG kit has significant advantages. Firstly, it has high sensitivity and can detect extremely small amounts of IgG antibodies. Even when the antibody content is low in the early stages of infection, it can be effectively recognized, which is helpful for early diagnosis of diseases. Secondly, it has strong specificity, and the antigens and antibodies used have been rigorously screened and optimized to accurately identify mumps virus IgG antibodies, avoiding cross reactivity with other virus antibodies or substances to the greatest extent possible and ensuring the accuracy of the test results. Furthermore, the operation is relatively simple, with complete components in the reagent kit and detailed operating instructions. Even non professionals can follow the standardized steps after simple training. Moreover, the kit has a wide range of applications, including serum, plasma, and even saliva samples, which can be used for detection to meet the needs of different scenarios.
In practical application scenarios, for suspected mumps patients, detecting IgG antibodies can assist doctors in determining whether the patient has been infected with the mumps virus. If IgG antibody is positive, combined with clinical symptoms, the diagnosis can be further clarified. In terms of disease prevention and control, conducting IgG antibody testing on specific populations (such as personnel in schools, kindergartens, and other key places) can help understand the infection status and immune level of the population, and provide a basis for formulating prevention and control strategies. In addition, when evaluating the effectiveness of mumps vaccination, detecting changes in IgG antibody levels in the recipient's body can intuitively reflect whether the vaccine has stimulated the body's immune response, and help optimize vaccination work.
